somas 44 pics

weight loss no prescription meridia

"Sanofi-aventis’ commitment to research and development in this area is rewarded today, and we hope it will benefit many patients suffering from this disease. Most common adverse reactions are diarrhea, nausea, vomiting, abdominal pain, asthenia (weakness) and cutaneous rash. In a placebo-controlled study in patients with severe heart failure requiring recent hospitalization or referral to a specialized heart failure clinic for worsening symptoms (the ANDROMEDA study), patients given dronedarone had a greater than two-fold increase in mortality. The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. somas 44 pics The ANDROMEDA and ATHENA trials were published in the New England Journal of Medicine (NEJM) respectively in 2008 and 2009.sanofi-aventis. somas 44 pics Treatment with Multaq can be initiated in an outpatient setting. xanax found next to heath ledger

Food and Drug Administration (FDA) has approved Multaq (dronedarone) 400 mg Tablets. Associated cardiovascular risk factors include age over 70 years, hypertension, diabetes, prior cerebrovascular accident, left atrial diameter greater than or equal to 50 mm or left ventricular ejection fraction [LVEF] <40%.S.5 million people in the European Union., Professor of Medicine & Director, Division of Cardiology, McMaster University, Hamilton, Canada, and co-principal investigator in the ATHENA study. somas 44 pics S. The ATHENA trial, which involved 4,628 patients with AF or AFL and more than 2,300 patients receiving Multaq on top of standard therapy, demonstrated a 24% reduction in time to first CV hospitalization or all-cause mortality (P<0. somas 44 pics This trial showed that Multaq (dronedarone) 400 mg BID, in addition to standard therapy, reduced the combined endpoint of cardiovascular hospitalization or death from any cause by 24% (p<0. viagra levitra cialis

"The FDA approval of Multaq is an important milestone in the management of atrial fibrillation or atrial flutter that demonstrates the commitment of sanofi-aventis to provide patients and physicians with important new medicines in therapeutic areas with significant healthcare needs," said Christopher A. Sanofi-aventis is listed in Paris and in New York . Viehbacher, Chief Executive Officer of sanofi-aventis. To ensure the use of Multaq in the appropriate patient population, sanofi-aventis U. somas 44 pics S. somas 44 pics " The incidence of atrial fibrillation is growing worldwide in relation to aging populations. The patients enrolled in ANDROMEDA had relatively severe heart failure and had been hospitalized, or referred to a specialty heart failure clinic for worsening symptoms.